bibliographic resource 334711 [br/334711]
https://w3id.org/oc/corpus/br/334711
- is a
-
- title
-
- Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-